Prescribing information and AE reporting can be found by clicking ‘Prescribing Information’ button in the header and footer of the website.
Utrogestan (micronised progesterone) 100mg is indicated for adjunctive use with oestrogen in postmenopausal women with an intact uterus, as hormone replacement therapy (HRT).1
Body identical micronised progesterone to greatly reduce the oestrogen-induced risk of endometrial cancer in women with an intact uterus.1,2,3
